PAR-4 (1-6) amide (human)
Need Assistance?
  • US & Canada:
    +
  • UK: +

PAR-4 (1-6) amide (human)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

PAR-4 (1-6) amide (human) is the tethered ligand sequence of human PAR-4.

Category
Peptide Inhibitors
Catalog number
BAT-015314
CAS number
245443-51-0
Molecular Formula
C28H42N8O8
Molecular Weight
618.69
PAR-4 (1-6) amide (human)
IUPAC Name
(2S)-2-[[2-[[(2S)-1-[(2S)-2-[(2-aminoacetyl)amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]pentanediamide
Synonyms
Coagulation Factor II Receptor-Like 3 (1-6) amide (human); GYPGQV-NH2; glycyl-L-tyrosyl-L-prolyl-glycyl-L-glutaminyl-L-valinamide; Thrombin Receptor-Like 3 (1-6) amide (human); Proteinase Activated Receptor 4 (1-6) amide (human)
Appearance
White Powder
Purity
≥95%
Density
1.327±0.06 g/cm3 (Predicted)
Boiling Point
1178.1±65.0°C (Predicted)
Sequence
Gly-Tyr-Pro-Gly-Gln-Val-NH2
Storage
Store at -20°C
Solubility
Soluble in Water
InChI
InChI=1S/C28H42N8O8/c1-15(2)24(25(31)41)35-26(42)18(9-10-21(30)38)33-23(40)14-32-27(43)20-4-3-11-36(20)28(44)19(34-22(39)13-29)12-16-5-7-17(37)8-6-16/h5-8,15,18-20,24,37H,3-4,9-14,29H2,1-2H3,(H2,30,38)(H2,31,41)(H,32,43)(H,33,40)(H,34,39)(H,35,42)/t18-,19-,20-,24-/m0/s1
InChI Key
NIUWXNGGQOLCDN-XHOYROJHSA-N
Canonical SMILES
CC(C)C(C(=O)N)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)NC(=O)CN
1. HPTLC Method for the Determination of Paracetamol, Pseudoephedrine and Loratidine in Tablets and Human Plasma
Eglal A Abdelaleem, Nehal Fayek Farid J Chromatogr Sci . 2016 Apr;54(4):647-52. doi: 10.1093/chromsci/bmv184.
A sensitive, accurate and selective high performance thin layer chromatography (HPTLC) method was developed and validated for the simultaneous determination of paracetamol (PAR), its toxic impurity 4-aminophenol (4-AP), pseudoephedrine HCl (PSH) and loratidine (LOR). The proposed chromatographic method has been developed using HPTLC aluminum plates precoated with silica gel 60 F254 using acetone-hexane-ammonia (4:5:0.1, by volume) as a developing system followed by densitometric measurement at 254 nm for PAR, 4-AP and LOR, while PSH was scanned at 208 nm. System suitability testing parameters were calculated to ascertain the quality performance of the developed chromatographic method. The method was validated with respect to USP guidelines regarding accuracy, precision and specificity. The method was successfully applied for the determination of PAR, PSH and LOR in ATSHI(®) tablets. The three drugs were also determined in plasma by applying the proposed method in the ranges of 0.5-6 µg/band, 1.6-12 µg/band and 0.4-2 µg/band for PAR, PSH and LOR, respectively. The results obtained by the proposed method were compared with those obtained by a reported HPLC method, and there was no significance difference between both methods regarding accuracy and precision.
Online Inquiry
Verification code
Inquiry Basket